Integrated Generic Platform offering Concept to Commercialization Solutions
Overview
At Cohance, our generic API platform offers an integrated solutions approach, uniquely positioned to serve our global customer base. With 30+ years of rich legacy, backed by deep chemistry capabilities, global regulatory expertise, and reliable supply network, we serve customers across 60+ countries, from 8 cGMP facilities, offering 50+ molecules across various therapeutic areas. We partner with leading pharma innovators and global generics, collaborating across the product lifecyle stage.
Why partner with us?
Why partner with us?
- Integrated Solutions Approach – Unified generic platform offering APIs, Pellets, and Finished Dosage Forms
- Chemistry at Core – 3 dedicated R&D centres with 150+ R&D strength
- Global Portfolio – 50+ molecules with customer base across 60+ countries
- Flexible Offerings – From Catalog to customized solutions
- Scale and Reliability – 8 cGMP sites offering kilo to multi-ton capacities
- Regulatory Compliance – Global regulatory accreditations such as USFDA, EU-GMP, ANVISA, PMDA, NPMA, Health Canada, TGA, KFDA, and more
Our Integrated Capabilities
APIs
- Partner of choice offering Scale, Compliance, and Reliability
- Deep chemistry capabilities, scalable capacities, and robust regulatory track record
- 1600+ KL operational capacity across 5 cGMP facilities with global accreditations – USFDA, EDQM, PMDA, NMPA, KFDA, ANVISA, and others
- Diverse portfolio of 50+ molecules covering multiple therapeutic areas
Pellets
- Pelletized intermediates for modified-release formulations
- Strong backward integration with in-house APIs
- BE-oriented design; strong regulatory expertise to support global filings
- 830+ MT operational capacity across 2 cGMP facilities
FDFs
- Vertically integrated CMO/CDMO solutions for generic pharma
- Multi-dosage capabilities including Oral Solids, Oral Liquids, Topical Cloths, Semi-solid Topicals, and others
- 3 cGMP facilities with global regulatory accreditations (USFDA, EU-GMP, Health Canada, TGA, etc.)
- Expertise in in-house development, tech-transfer, dossier filing, and lifecycle support
Facilities
API R&D, Genome Valley
Hyderabad, India
API R&D, Ankaleshwar
Gujarat, India
API Unit-I, Jaggayapet
Vijayawada, India
API Unit-II, Achutapuram
Vizag, India
API Unit-III, Ankaleshwar
Gujarat, India
CDMO Unit-III, Pashamylaram
Hyderabad, India
Designed to seamlessly scale from clinical to commercial manufacturing, these facilities are compliant with global regulatory standards including the US FDA.
FDF Unit-I, Nacharam
Hyderabad, India
FDF Unit-II, Jadcherla
Hyderabad, India
Designed to seamlessly scale from clinical to commercial manufacturing, these facilities are compliant with global regulatory standards including the US FDA.
FDF Unit-I, Nacharam
Hyderabad, India
FDF Unit-II, Jadcherla
Hyderabad, India
FDF Unit-III, Pashamylaram
Hyderabad, India
FDF Unit IV, Shamshabad
Hyderabad, India
Contact Us